Skip Navigation


JAC Advance Access originally published online on August 26, 2009
Journal of Antimicrobial Chemotherapy 2009 64(5):1013-1017; doi:10.1093/jac/dkp314
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
64/5/1013    most recent
dkp314v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Vera-Cabrera, L.
Right arrow Articles by Castro-Garza, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vera-Cabrera, L.
Right arrow Articles by Castro-Garza, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Original research

Activity of novel oxazolidinones against Nocardia brasiliensis growing within THP-1 macrophages

Lucio Vera-Cabrera1,*, Nelly A. Espinoza-González1, Oliverio Welsh1, Jorge Ocampo-Candiani1 and Jorge Castro-Garza2

1 Servicio de Dermatología, Hospital Universitario ‘José E. González’, Monterrey, N.L., México 2 Centro de Investigación Biomédica del Noreste, IMSS, Monterrey, N.L., México

Received 29 June 2009; returned 20 July 2009; revised 4 August 2009; accepted 4 August 2009

* Corresponding author. Tel: +52-81-8348-0383; Fax: +52-81-8348-4407; E-mail: luvera_99{at}yahoo.com

Background: Nocardia are organisms that can escape the effects of both immune response and antimicrobial agents, due to their potential capacity to grow intracellularly. In previous studies, we found that experimental oxazolidinones, DA-7157 and DA-7218, are active both in vitro and in vivo.

Objectives: In this study, we compare the ability of linezolid, DA-7157 and DA-7218 to inhibit intracellular growth of Nocardia brasiliensis within the human monocyte cell line THP-1.

Methods and results: The addition of oxazolidinones to the infected macrophage monolayer at concentrations 0.25x, 1x, 4x and 16x the MIC for N. brasiliensis resulted in an inhibitory effect on bacterial growth as follows DA-7157 ≥ DA-7218 > linezolid.

Conclusions: The excellent intracellular antimicrobial activity detected suggests that these compounds could be effective in the treatment of actinomycetoma. However, more studies are needed both in vitro and in vivo, including clinical trials, to confirm this issue.

Keywords: actinomycetoma , linezolid , DA-7218 , DA-7867


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.